| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. (XENE) has 5 insiders with recent SEC Form 4 filings, including 2 buys and 16 sells. XENE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 30.0K | $1.64M | - | |
| Other | 20.0K | $1.10M | - | |
| CEO | 19.9K | $1.09M | - | |
| Other | 7.3K | $400.0K | - | |
| Other | 7.1K | $387.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | Robin Sherrington50 | EVP, Strategy &Innovation | Sale+OE | 21,710 | $30.50 | $662,207.60 | -18.0% | -7.4% | +22.4% | |
| Jan 21, 2022 | Kenney Christopher John56 | Chief Medical Officer | Buy | 700 | $28.81 | $20,167.00 | New | +25.8% | +40.3% | |
| Dec 6, 2021 | Von Seggern Christopher | Chief Commercial Officer | Buy | 4,000 | $24.40 | $97,600.00 | New | +22.2% | +53.6% | |
| Nov 15, 2021 | Pimstone Simon N.60 | Director | Sell | 17,557 | $31.33 | $550,060.81 | -7.7% | -3.4% | +9.8% | |
| May 28, 2021 | Robin Sherrington50 | EVP, Strategy &Innovation | Sale+OE | 6,067 | $18.81 | $114,120.27 | -8.3% | -8.0% | +48.8% | |
| May 27, 2021 | Holler Frank A | Director | Sale+OE | 11,064 | $18.68 | $206,701.31 | -3.6% | -10.1% | +45.4% | |
| Jun 1, 2020 | Pimstone Simon N.60 | CEO | Sell | 8,000 | $14.16 | $113,240.00 | -1.5% | - | - | |
| Sep 20, 2019 | Pimstone Simon N.60 | CEO | Sell | 10,395 | $9.51 | $98,856.45 | -3.9% | - | - | |
| Sep 20, 2019 | Holler Frank A | Director | Sell | 12,806 | $9.32 | $119,336.34 | -5.0% | - | - | |
| Sep 18, 2019 | Holler Frank A | Director | Sell | 9,437 | $9.30 | $87,778.12 | -3.4% | - | - |